FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366237302> ?p ?o ?g. }

• W4366237302 endingPage "1725" @default.
• W4366237302 startingPage "1710" @default.
• W4366237302 abstract "Abstract Background and Aims Treatment of depression‐related psychological factors related to smoking behavior may improve rates of cessation among adults with major depressive disorder (MDD). This study measured the efficacy and safety of 12 weeks of behavioral activation for smoking cessation (BASC), varenicline and their combination. Design, Setting, Participants This study used a randomized, placebo‐controlled, 2 × 2 factorial design comparing BASC versus standard behavioral treatment (ST) and varenicline versus placebo, taking place in research clinics at two urban universities in the United States. Participants comprised 300 hundred adult smokers with current or past MDD. Interventions BASC integrated behavioral activation therapy and ST to increase engagement in rewarding activities by reducing avoidance, withdrawal and inactivity associated with depression. ST was based on the 2008 PHS Clinical Practice Guideline. Both treatments consisted of eight 45‐min sessions delivered between weeks 1 and 12. Varenicline and placebo were administered for 12 weeks between weeks 2 and 14. Measurements Primary outcomes were bioverified intent‐to‐treat (ITT) 7‐day point‐prevalence abstinence at 27 weeks and adverse events (AEs). Findings No significant interaction was detected between behavioral treatment and pharmacotherapy at 27 weeks (χ 2 (1) = 0.19, P = 0.67). BASC and ST did not differ (χ 2 (1) = 0.43, P = 0.51). Significant differences in ITT abstinence rates (χ 2 (1) = 4.84, P = 0.03) emerged among pharmacotherapy arms (16.2% for varenicline, 7.5% for placebo), with results favoring varenicline over placebo (rate ratio = 2.16, 95% confidence interval = 1.08, 4.30). All significant differences in AE rates after start of medication were higher for placebo than varenicline. Conclusion A randomized trial in smokers with major depressive disorder found that varenicline improved smoking abstinence versus placebo at 27 weeks without elevating rates of adverse events. Behavioral activation for smoking cessation did not outperform standard behavioral treatment, with or without adjunctive varenicline therapy." @default.
• W4366237302 created "2023-04-20" @default.
• W4366237302 creator A5001693867 @default.
• W4366237302 creator A5010111919 @default.
• W4366237302 creator A5027544810 @default.
• W4366237302 creator A5030835336 @default.
• W4366237302 creator A5037191310 @default.
• W4366237302 creator A5054352048 @default.
• W4366237302 creator A5058115883 @default.
• W4366237302 creator A5061994382 @default.
• W4366237302 creator A5066837078 @default.
• W4366237302 creator A5078402791 @default.
• W4366237302 creator A5082109429 @default.
• W4366237302 creator A5087014245 @default.
• W4366237302 creator A5087840284 @default.
• W4366237302 creator A5088343896 @default.
• W4366237302 creator A5089499835 @default.
• W4366237302 creator A5090146536 @default.
• W4366237302 date "2023-05-03" @default.
• W4366237302 modified "2023-10-09" @default.
• W4366237302 title "Efficacy and safety of combination behavioral activation for smoking cessation and varenicline for treating tobacco dependence among individuals with current or past major depressive disorder: A 2 × 2 factorial, randomized, placebo‐controlled trial" @default.
• W4366237302 cites W113538278 @default.
• W4366237302 cites W1490356790 @default.
• W4366237302 cites W1570622790 @default.
• W4366237302 cites W1587682423 @default.
• W4366237302 cites W1630588036 @default.
• W4366237302 cites W1840852078 @default.
• W4366237302 cites W1967898187 @default.
• W4366237302 cites W1968185435 @default.
• W4366237302 cites W1981105665 @default.
• W4366237302 cites W1984116490 @default.
• W4366237302 cites W1986334160 @default.
• W4366237302 cites W2006024465 @default.
• W4366237302 cites W2008817040 @default.
• W4366237302 cites W2016854545 @default.
• W4366237302 cites W2026845717 @default.
• W4366237302 cites W2028518233 @default.
• W4366237302 cites W2044625851 @default.
• W4366237302 cites W2050783033 @default.
• W4366237302 cites W2053780127 @default.
• W4366237302 cites W2054007622 @default.
• W4366237302 cites W2065460348 @default.
• W4366237302 cites W2067411780 @default.
• W4366237302 cites W2070192651 @default.
• W4366237302 cites W2078032875 @default.
• W4366237302 cites W2084118333 @default.
• W4366237302 cites W2087985824 @default.
• W4366237302 cites W2095598636 @default.
• W4366237302 cites W2099333672 @default.
• W4366237302 cites W2099402142 @default.
• W4366237302 cites W2100210143 @default.
• W4366237302 cites W2100661708 @default.
• W4366237302 cites W2103993300 @default.
• W4366237302 cites W2108315730 @default.
• W4366237302 cites W2109063172 @default.
• W4366237302 cites W2111167996 @default.
• W4366237302 cites W2112669742 @default.
• W4366237302 cites W2116739230 @default.
• W4366237302 cites W2116886816 @default.
• W4366237302 cites W2124679681 @default.
• W4366237302 cites W2124905812 @default.
• W4366237302 cites W2126866313 @default.
• W4366237302 cites W2136511536 @default.
• W4366237302 cites W2138106394 @default.
• W4366237302 cites W2140976757 @default.
• W4366237302 cites W2141348739 @default.
• W4366237302 cites W2142495742 @default.
• W4366237302 cites W2148083007 @default.
• W4366237302 cites W2151387528 @default.
• W4366237302 cites W2153613936 @default.
• W4366237302 cites W2164454298 @default.
• W4366237302 cites W2166328543 @default.
• W4366237302 cites W2340896985 @default.
• W4366237302 cites W2417827962 @default.
• W4366237302 cites W2520553955 @default.
• W4366237302 cites W2755722512 @default.
• W4366237302 cites W2898946532 @default.
• W4366237302 cites W2914865446 @default.
• W4366237302 cites W2948641443 @default.
• W4366237302 cites W2955525647 @default.
• W4366237302 cites W2978389675 @default.
• W4366237302 cites W3009826353 @default.
• W4366237302 cites W3179730132 @default.
• W4366237302 cites W3186391100 @default.
• W4366237302 cites W3203310594 @default.
• W4366237302 cites W3216738649 @default.
• W4366237302 cites W4224940402 @default.
• W4366237302 cites W4229455136 @default.
• W4366237302 cites W4247665917 @default.
• W4366237302 cites W4296148892 @default.
• W4366237302 doi "https://doi.org/10.1111/add.16209" @default.
• W4366237302 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37069490" @default.
• W4366237302 hasPublicationYear "2023" @default.
• W4366237302 type Work @default.
• W4366237302 citedByCount "2" @default.
• W4366237302 countsByYear W43662373022023 @default.
• W4366237302 crossrefType "journal-article" @default.
• W4366237302 hasAuthorship W4366237302A5001693867 @default.

• next